This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Oncobiologics Inc. (biosimilars for immune conditions and cancer) netted $32.5mm through its initial public offering of 5.8mm units at $6. Each unit held one share, half of a Series A warrant (each whole warrant is good for one share at $6.60 for nine months) and half of a Series B warrant (each whole Series B warrant is good for one share at $8.50 for two years). The company filed in February and last month announced that it intended to sell 5mm shares at a range of $11-13.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?